These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7640629)

  • 1. Role of platelets and complement in the clearance of epimastigote forms of Trypanosoma cruzi.
    Umekita LF; Piazza RM; Mota I
    Braz J Med Biol Res; 1994 Oct; 27(10):2391-9. PubMed ID: 7640629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One fate of epimastigote forms of Trypanosoma cruzi injected in mice. An ultrastructural study.
    Umekita LF; Carneiro SM; Mota I
    J Parasitol; 1998 Dec; 84(6):1190-5. PubMed ID: 9920312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the microcirculatory network during the clearance of epimastigote forms of Trypanosoma cruzi: an intravital microscopic study.
    Umekita LF; Lopes-Ferreira M; Piazza RM; Umezawa ES; Nascimento MS; Farsky SH; Mota I
    J Parasitol; 2001 Feb; 87(1):114-7. PubMed ID: 11227874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro lysis of sensitized Trypanosoma cruzi by platelets: role of C3b receptors.
    Umekita LF; Mota I
    Parasite Immunol; 1989 Sep; 11(5):561-6. PubMed ID: 2531362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The possible mechanism of action of IgG antibodies and platelets protecting against Trypanosoma cruzi infection.
    Takehara HA; Mota I
    Braz J Med Biol Res; 1991; 24(8):759-65. PubMed ID: 1797263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of platelets in the in vivo removal of T. cruzi from circulation.
    Umekita LF; Mota I
    Braz J Med Biol Res; 1990; 23(6-7):593-6. PubMed ID: 2101079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of complement to trypomastigotes of a Brazil strain of Trypanosoma cruzi: evidence for heterogeneity within the strain.
    Jacobson KC; Washburn RG; Kuhn RE
    J Parasitol; 1992 Aug; 78(4):697-704. PubMed ID: 1635029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Trypanosoma cruzi membrane components on the formation of the classical pathway C3 convertase.
    Kipnis TL; Tambourgi DV; Sucupira M; Dias-da-Silva W
    Braz J Med Biol Res; 1986; 19(2):271-8. PubMed ID: 3548858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evasion of Trypanosoma cruzi from complement lysis.
    Kipnis TL; da Silva WD
    Braz J Med Biol Res; 1989; 22(1):1-16. PubMed ID: 2667667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi: fibronectin promotes uptake of epimastigote culture forms by human neutrophils and monocytes.
    Cornette J; Capron A; Ouaissi MA
    Int Arch Allergy Appl Immunol; 1988; 86(2):139-46. PubMed ID: 3292436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of C3 depletion on the clearance of Trypanosoma cruzi induced by IgG antibodies.
    Mota I; Umekita LF
    Immunol Lett; 1989 Jun; 21(3):223-5. PubMed ID: 2504665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi: differences in cell surface interaction of circulating (trypomastigote) and culture (epimastigote) forms with macrophages.
    Zenian A; Kierszenbaum F
    J Parasitol; 1983 Aug; 69(4):660-5. PubMed ID: 6355428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma musculi infections in normocomplementemic, C5-deficient, and C3-depleted mice.
    Jarvinen JA; Dalmasso AP
    Infect Immun; 1977 May; 16(2):557-63. PubMed ID: 863515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of C3 fragments to the Trypanosoma cruzi surface in the absence of specific antibodies and without activation of the complement cascade.
    Krettli AU; Pontes de Carvalho LC
    Clin Exp Immunol; 1985 Nov; 62(2):270-7. PubMed ID: 3910312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor-like activity isolated from Trypanosoma cruzi.
    Gomes MT; Monteiro RQ; Grillo LA; Leite-Lopes F; Stroeder H; Ferreira-Pereira A; Alviano CS; Barreto-Bergter E; Neto HC; Cunha E Silva NL; Almeida IC; Soares RM; Lopes AH
    Int J Parasitol; 2006 Feb; 36(2):165-73. PubMed ID: 16337632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies on epimastigote and metacyclic stages of Trypanosoma cruzi. II. Selective lysis by rodent sera.
    Chao D; Hsu YP; Chan CH; Chen YA
    Int J Zoonoses; 1985 Dec; 12(4):323-30. PubMed ID: 3939135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
    Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
    Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human platelet activation by C3a and C3a des-arg.
    Polley MJ; Nachman RL
    J Exp Med; 1983 Aug; 158(2):603-15. PubMed ID: 6604123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of macrophage-Trypanosoma cruzi interaction by concanavalin A and differential binding of bloodstream and culture forms to the macrophage surface.
    Zenian A; Kierszenbaum F
    J Parasitol; 1982 Jun; 68(3):408-15. PubMed ID: 7047708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human platelet-initiated formation and uptake of the C5-9 complex of human complement.
    Zimmerman TS; Kolb WP
    J Clin Invest; 1976 Jan; 57(1):203-11. PubMed ID: 812888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.